These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 32378043)
1. Cucurbitane-Type Triterpene Glycosides from Momordica charantia and Their α-Glucosidase Inhibitory Activities. Gao Y; Chen JC; Peng XR; Li ZR; Su HG; Qiu MH Nat Prod Bioprospect; 2020 Jun; 10(3):153-161. PubMed ID: 32378043 [TBL] [Abstract][Full Text] [Related]
2. alpha-Glucosidase inhibition properties of cucurbitane-type triterpene glycosides from the fruits of Momordica charantia. Nhiem NX; Kiem PV; Minh CV; Ban NK; Cuong NX; Tung NH; Ha le M; Ha do T; Tai BH; Quang TH; Ngoc TM; Kwon YI; Jang HD; Kim YH Chem Pharm Bull (Tokyo); 2010 May; 58(5):720-4. PubMed ID: 20460803 [TBL] [Abstract][Full Text] [Related]
3. Cucurbitane-type triterpene glycosides from the fruits of Momordica charantia. Liu Y; Ali Z; Khan IA Planta Med; 2008 Aug; 74(10):1291-4. PubMed ID: 18622906 [TBL] [Abstract][Full Text] [Related]
4. Anti-Inflammatory, Antidiabetic Properties and In Silico Modeling of Cucurbitane-Type Triterpene Glycosides from Fruits of an Indian Cultivar of Perera WH; Shivanagoudra SR; Pérez JL; Kim DM; Sun Y; K Jayaprakasha G; S Patil B Molecules; 2021 Feb; 26(4):. PubMed ID: 33669312 [TBL] [Abstract][Full Text] [Related]
5. Cucurbitane triterpenoids from the fruit of Momordica charantia L. and their anti-hepatic fibrosis and anti-hepatoma activities. Yue J; Sun Y; Xu J; Cao J; Chen G; Zhang H; Zhang X; Zhao Y Phytochemistry; 2019 Jan; 157():21-27. PubMed ID: 30352327 [TBL] [Abstract][Full Text] [Related]
6. Cucurbitane-type triterpene glycosides from the fruits of Momordica charantia. Yen PH; Dung DT; Nhiem NX; Anh Hle T; Hang DT; Yen DT; Cuc NT; Ban NK; Van Minh C; Van Kiem P Nat Prod Commun; 2014 Mar; 9(3):383-6. PubMed ID: 24689223 [TBL] [Abstract][Full Text] [Related]
7. Cucurbitane-type triterpenoids from the fruits of Momordica charantia and their cancer chemopreventive effects. Akihisa T; Higo N; Tokuda H; Ukiya M; Akazawa H; Tochigi Y; Kimura Y; Suzuki T; Nishino H J Nat Prod; 2007 Aug; 70(8):1233-9. PubMed ID: 17685651 [TBL] [Abstract][Full Text] [Related]
8. Metabolite Profile of Cucurbitane-Type Triterpenoids of Bitter Melon (Fruit of Lee YH; Yoon SY; Baek J; Kim SJ; Yu JS; Kang H; Kang KS; Chung SJ; Kim KH J Agric Food Chem; 2021 Feb; 69(6):1816-1830. PubMed ID: 33406828 [TBL] [Abstract][Full Text] [Related]
9. One new 19-nor cucurbitane-type triterpenoid from the stems of Momordica charantia. Li YC; Xu XJ; Yang J; Wu XG; Fu QY Nat Prod Res; 2016; 30(8):973-8. PubMed ID: 26539691 [TBL] [Abstract][Full Text] [Related]
10. Four new cucurbitane-type triterpenes from Momordica charantia L. with their cytotoxic activities and protective effects on H Yue J; Sun Y; Xu J; Zhang X; Zhao Y J Nat Med; 2020 Jan; 74(1):34-40. PubMed ID: 31256310 [TBL] [Abstract][Full Text] [Related]
11. Structures of new cucurbitane-type triterpenes and glycosides, karavilagenins and karavilosides, from the dried fruit of Momordica charantia L. in Sri Lanka. Nakamura S; Murakami T; Nakamura J; Kobayashi H; Matsuda H; Yoshikawa M Chem Pharm Bull (Tokyo); 2006 Nov; 54(11):1545-50. PubMed ID: 17077551 [TBL] [Abstract][Full Text] [Related]
12. Kaguacidine A: a novel spirohydantoin-containing cucurbitane glycoside from vines of Huang HT; Lo IW; Lin YC; Geng-You L; Lin YS; Zhang LJ; Li TL; Liaw CC; Kuo YH Nat Prod Res; 2024 Jul; 38(13):2179-2186. PubMed ID: 36606546 [TBL] [Abstract][Full Text] [Related]
13. Cucurbitane-type triterpenoids from the vines of Momordica charantia and their anti-inflammatory, cytotoxic, and antidiabetic activity. Liaw CC; Huang HT; Liu HK; Lin YC; Zhang LJ; Wei WC; Shen CC; Wu CL; Huang CY; Kuo YH Phytochemistry; 2022 Mar; 195():113026. PubMed ID: 34890886 [TBL] [Abstract][Full Text] [Related]
14. Cucurbitane-type triterpene glycosides from the fruits of Momordica charantia. Nguyen XN; Phan VK; Chau VM; Ninh KB; Nguyen XC; Le MH; Bui HT; Tran HQ; Nguyen HT; Kim YH Magn Reson Chem; 2010 May; 48(5):392-6. PubMed ID: 20225243 [TBL] [Abstract][Full Text] [Related]
15. Quantitative determination of cucurbitane-type triterpenes and triterpene glycosides in dietary supplements containing bitter melon (Momordica charantia) by HPLC-MS/MS. Ma J; Krynitsky AJ; Grundel E; Rader JI J AOAC Int; 2012; 95(6):1597-608. PubMed ID: 23451374 [TBL] [Abstract][Full Text] [Related]
16. Antiproliferative and hypoglycemic cucurbitane-type glycosides from the fruits of Momordica charantia. Hsiao PC; Liaw CC; Hwang SY; Cheng HL; Zhang LJ; Shen CC; Hsu FL; Kuo YH J Agric Food Chem; 2013 Mar; 61(12):2979-86. PubMed ID: 23432055 [TBL] [Abstract][Full Text] [Related]
17. Cucurbitane-type triterpenoids from the stems and leaves of Momordica charantia. Zhao GT; Liu JQ; Deng YY; Li HZ; Chen JC; Zhang ZR; Zhou L; Qiu MH Fitoterapia; 2014 Jun; 95():75-82. PubMed ID: 24631764 [TBL] [Abstract][Full Text] [Related]
18. Medicinal foodstuffs. XXI. Structures of new cucurbitane-type triterpene glycosides, goyaglycosides-a, -b, -c, -d, -e, -f, -g, and -h, and new oleanane-type triterpene saponins, goyasaponins I, II, and III, from the fresh fruit of Japanese Momordica charantia L. Murakami T; Emoto A; Matsuda H; Yoshikawa M Chem Pharm Bull (Tokyo); 2001 Jan; 49(1):54-63. PubMed ID: 11201226 [TBL] [Abstract][Full Text] [Related]
19. New compounds from acid hydrolyzed products of the fruits of Momordica charantia L. and their inhibitory activity against protein tyrosine phosphatas 1B. Zeng K; He YN; Yang D; Cao JQ; Xia XC; Zhang SJ; Bi XL; Zhao YQ Eur J Med Chem; 2014 Jun; 81():176-80. PubMed ID: 24836069 [TBL] [Abstract][Full Text] [Related]
20. Cucurbitane-type compounds from Momordica charantia: Isolation, in vitro antidiabetic, anti-inflammatory activities and in silico modeling approaches. Shivanagoudra SR; Perera WH; Perez JL; Athrey G; Sun Y; Jayaprakasha GK; Patil BS Bioorg Chem; 2019 Jun; 87():31-42. PubMed ID: 30856374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]